SOBI's recent partnership deal with AUXL could be a template for SVNT
AMGN, BMY, NVS, Takeda, SNY & AZN could also execute a similar deal with SVNT bringing in much needed cash and mktg expertise. Peak world rev estimates for K might then shoot up to $250-$300 mil,factoring in addtl price increases, geographic launches and modest label expansion.
I would not be surprised to see a deal between SOBI and SVNT similar to the AUXL deal. I think some such deal is probably in the works. There is a reason Savient and Sobi teamed up. There is a reason Meeker is on the board. We are getting ready to find out.
Could you believe that dumass boby tried to compare Savient to Nortel. That's pitiful.
It might be also a good time to start accumulating shares of AMGN, BMY, NVS, Takeda, SNY & AZN. Any one of them could end up with Krystexxa, once SVNT goes through the bankruptcy process and auctions off Krystexxa. The aquirer would not only have EU but also get the worldwide market for around 100 million.
Bopy, I thought you were down on SVNT yet you acknowledge here that the owner of 'K' commands " EU but also get the worldwide market for around 100 million". Which is it, does SVNT have considerable shareholder value or like you say and WANT - going bankrupt? kg
A better template would be Nortel..We are in the transition now u see into bankruptcy mode....So for Post Bankruptcy scenario..Nortel sold its R&D and patents for a hefty price. They paid off quite their debt.
Savient needs to do the same. It is not good to keep 300 million in debt and keep burning cash for a revenue of 20 million per year when annual cost is over 100 million. For sake of patients, for sake of K and for RCG, Savient should liquidate as soon as possible.